ResMed
RMD • NYSE
ResMed is a medical - instruments & supplies company in the healthcare sector trading on NYSE, led by CEO Michael J. Farrell, with a market cap of $32.1B.
CEOMichael J. Farrell
Next Earnings
Upcoming earnings announcement for ResMed
Date
Wednesday, April 22, 2026 (in 3 weeks)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q3 2026
EPS Estimate
$2.79
Revenue Estimate
$1.4B
Earnings History
Past 12 earnings reports for ResMed
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Jan 29, 2026 | Q2 2026 | $2.81Est: $2.71 | +3.7% | $1.4BEst: $1.4B | +2.0% | — |
| Oct 30, 2025 | Q1 2026 | $2.55Est: $2.50 | +2.0% | $1.3BEst: $1.3B | +0.6% |  10-Q |
| Jul 31, 2025 | Q4 2025 | $2.55Est: $2.47 | +3.2% | $1.3BEst: $1.3B | +1.6% | 10-K |
| Apr 23, 2025 | Q3 2025 | $2.37Est: $2.36 | +0.4% | $1.3BEst: $1.3B | +0.9% | 10-Q |
| Jan 30, 2025 | Q2 2025 | $2.43Est: $2.31 | +5.2% | $1.3BEst: $1.3B | +0.9% | 10-Q |
| Oct 24, 2024 | Q1 2025 | $2.20Est: $2.04 | +7.8% | $1.2BEst: $1.2B | +3.8% | 10-Q |
| Aug 1, 2024 | Q4 2024 | $2.08Est: $2.06 | +1.0% | $1.2BEst: $1.2B | +2.8% | 10-K |
| Apr 25, 2024 | Q3 2024 | $2.13Est: $1.91 | +11.5% | $1.2BEst: $1.2B | +2.3% | 10-Q |
| Jan 24, 2024 | Q2 2024 | $1.88Est: $1.79 | +5.0% | $1.2BEst: $1.2B | +1.1% | 10-Q |
| Oct 26, 2023 | Q1 2024 | $1.64Est: $1.62 | +1.2% | $1.1BEst: $1.1B | +0.2% | 10-Q |
| Aug 3, 2023 | Q4 2023 | $1.60Est: $1.67 | -4.2% | $1.1BEst: $1.1B | +0.2% | 10-K |
| Apr 27, 2023 | Q3 2023 | $1.68Est: $1.59 | +5.7% | $1.1BEst: $1.1B | +6.4% | — |